---
title: "Yildirim returns to Amed squad after recovering from muscle injury"
url: "https://riyadaty.com/en/news/yildirim-returns-to-amed-squad-after-recovering-from-muscle-injury"
language: "en"
description: "Amed player M. Yildirim has recovered from a muscle injury that kept him out for 7 days, and is now available to play for his team again."
---

# Yildirim returns to Amed squad after recovering from muscle injury

Amed player M. Yildirim has recovered from a muscle injury that kept him out for 7 days, and is now available to play for his team again.

[Kareem Al-Saleh](https://riyadaty.com/en/author/kareem-al-saleh-2) Editor Published 17 October 2026، 00:16 ، updated 12:00 Saudi time

![Yildirim returns to Amed squad after recovering from muscle injury](https://riyadaty.com/img/blog-1200.jpg/covers/95a7a5761a1ba2ede1e89867a04a230874d29f89.webp)

Yildirim returns to Amed squad after recovering from muscle injury

[Amed](https://riyadaty.com/en/team/amed-182) club announced the return of their player [M. Yildirim](https://riyadaty.com/en/player/m-yildirim-13964) to training and matches after recovering from a muscle injury.

The player had been absent from the pitch since 10 October 2026 due to the injury, and officially became available again on 17 October 2026, after an absence of 7 days.

Yildirim is expected to be ready to play in his team's next match against Konyaspor, as part of matchday 8 of the Turkish Super Lig for the 2026/27 season.

The match will be held at Amed's stadium, kicking off at 16:00 Damascus time.

The match will be broadcast on beIN SPORTS and TOD.

[All stories by Kareem Al-Saleh](https://riyadaty.com/en/author/kareem-al-saleh-2) · [Editorial policy](https://riyadaty.com/en/editorial-policy)

## Sign in to join the conversation

Comment, reply to other readers and like what you agree with.

[Sign in](https://riyadaty.com/en/login?redirect=%2Fen%2Fnews%2Fyildirim-returns-to-amed-squad-after-recovering-from-muscle-injury%23comments) [Create account](https://riyadaty.com/en/register)

No comments yet. Be the first.